The prevalence and comorbidity rates of ADHD in school-age children in Turkey are similar to those found in previous studies in other countries.

No abstract

Bu çalışmanın amacı Dikkat Eksikliği/Hiperaktivite Bozukluğu (DEHB) tanılı 11-17 yaş arası çocuk ve ergenlerin yeme tutumları ve uyku paternlerinin sağlıklı kontrollerle karşılaştırılarak incelenmesidir. Gereç ve Yöntemler: 11-17 yaş arası 35 DEHB tanılı çocuk ve ergen ile yaş ve cinsiyet olarak eşleştirilmiş herhangi bir psikopatolojisi olmayan 11-17 yaş arası 35 sağlıklı kontrol örneklemi oluşturdu. Her iki gruba sosyodemografik veri formu, Okul Çağı Çocukları için Duygulanım Bozuklukları ve Şizofreni Formu-Şimdi ve Yaşam boyu şekli Türkçe Uyarlaması (K-SADS-PL), Yeme Tutumu Testi (YTT), Düzey-2 Uyku Bozukluğu-6-17 Yaş Arası Çocuğun Ebeveyn Formu, Düzey-2 Uyku Bozukluğu-11-17 Yaş Arası Çocuk formu uygulandı. Bulgular: DEHB tanılı grup ve kontrol grubu arasında Düzey-2 Uyku Ölçeği Ebeveyn Formu ve YTT toplam puanlarında istatistiksel olarak anlamlı fark saptandı (p<0,001). Ebeveynleri tarafından uyku sorunu yaşadığı belirtilen çocukların yeme tutumları açısından da korele olacak şekilde sorun yaşadığı saptandı (p=0,018). Benlik saygısı çok sorunlu olan çocuklarda uyku ölçeği ebeveyn formu puanlarının istatistiksel olarak anlamlı olarak farklılaştığı saptandı (p=0,019). Sonuç: Çalışmamızın sonuçları uyku ve yeme sorunlarının DEHB tanılı çocuk ve ergenlerde sanıldığından yaygın olabileceğini, klinik değerlendirmelerde ayrıca göz önünde bulundurulması gerektiğini düșündürmektedir.

Factors affecting burden of psychopharmacological medication in patients with autism spectrum disorder: the importance of early diagnosis Objective: The aim of the present study is to specify the frequency in psychopharmacological medication use in children with autism spectrum disorder (ASD) and determine their age range at diagnosis. Methods: Five hundred and twenty three children with ASD who applied to Dr. Sami Ulus Maternity and Children Research and Training Hospital between 2010 -2015 were reviewed retrospectively. Data has been obtained from computerized hospital information system. Individuals with the diagnosis of Autism (F84.0), Atypical Autism (F84.1) and Pervasive Developmental Disorder Not Other Specified (F84.9) were screened.Results: Psychotropic medication was recommended to 28.5% of the 523 children and adolescents diagnosed with ASD. Antipsychotics were the most common drugs of choice among psychotropic medications. The mean age at diagnosis of patients taking psychotropic medication was significantly higher than that of the patients who were not taking psychotropic medication (t=-3.064; p<0.01). The rate of psychotropic drug usage in female patients was significantly high than male patients (χ²=6.675; p=0.01). Conclusion:The results of the present study suggest that the delay of diagnosis can be included as a factor for psychotropic medication need of patients with ASD. Nearly half of the patients have been diagnosed in the first three years of their life. For further benefits of studies in Turkey, evaluating the psychopharmacological drug prescription rate, age of diagnosis and related factors to determine the present situation of psychotropic medication in our country will be necessary.

Objective: This study aims to examine the psychopathology, quality of life perception, eating behaviors and self-image of children and adolescents who are diagnosed with obesity; as well as their parents' behaviour, coping skills and the relations between these conditions. Methods: In this study, 30 patients between the ages of 8 -18 who have consulted the University of Akdeniz Pediatric Endocrinology Department and had BMI standard deviation above 2 and had no mental retardation or received no previous psychiatric consultations on the obesity were enrolled. Our control group included 30 healthy children and adolescents who were matching on the same demographic information (gender and age) with the treatment (patient) group, and they had no previous medical or psychiatric illnesses. The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version was administered to both groups, and the Rosenberg Self Image Scale was used to determine their self-images. The Quality of Life Scale for Children was administered to the children and adolescents as well as to their parents. To determine the methods of child rearing and coping strategies with stress, parents were administered the Family Life and Child Rearing Demeanours Scale and the Coping Strategies Scale. Results: There were no significant sociodemographic differences between the two groups except for parents' educational level and socioeconomic status. As we found no differences on parenting styles and coping strategies, a higher percentage of psychiatric illnesses were detected in our study and the quality of life perception of parents was found lower in the obese group. Self-image scores were not varied between obese children and healthy controls. İt was observed that obese group children's mother have more likley high obesity rates than the mothers in the control group children. Conclusions: As a result of this study, psychiatric disorders were observed more frequently in obese children and adolescents. The perception of quality of life for obese children and adolescents seem alike with control groups' perception. However, the fact that obese children and adolescents' parents claim that their children's quality of life is not equal to other groups shows that obese children and adolescents are less aware of health condition and following problems they have and might possible attain in the future.[Abstract:0106][Addiction]